glp 1 coverage GLP-1 in Employer Plans Could Nearly Double in 2024 How to Find a Health
Description
GLP-1 Pharmacology Glucagon-like peptide 1 agonists simulate the action of incretin, which is a hormone produced by the small intestines, that bind to the GLP-1 receptor
Common side effects of GLP-1 agonists While patients generally tolerate GLP-1 agonists well, some may experience side effects, especially when starting treatment
However, this study was limited by small sample size and nonrandomized character (39)
8,9,30 The agents used in these trials, including higher-dose semaglutide (2.4 mg) and the dual GLP-1/GIP receptor agonist tirzepatide, have demonstrated compelling benefits
